Market Research Logo

Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

“The sepsis diagnostics market projected to grow at a CAGR of 9.1%.”
The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and commercialization and availability of a wide variety of approved sepsis diagnostic devices are the factors expected to drive the market during the study period. However, the lack of established reimbursement policies for sepsis and high cost of automated diagnostic devices are the major factors restraining the growth of this market.

“Microbiology to command the largest share of the sepsis diagnostics market in 2018.”
On the basis of technology, the microbiology segment is expected to command the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the growing use of blood culture techniques for the diagnosis of sepsis.

“The blood culture media segment is expected to be the fastest-growing segment during the forecast period.”
On the basis of products, the market is segmented into blood culture media, instruments, assays & reagents, and software. The blood culture media segment is expected to be the fastest-growing segment during the forecast period. The large share of this segment can be attributed to the fact that blood culture testing is used as the standard diagnostic method for the diagnosis and identification of sepsis across the globe.

“Asia Pacific is expected grow at the highest CAGR during the forecast period.”
Geographically, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period due to the high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, and developing healthcare infrastructure in this region.

Breakdown of supply-side primary interviews:
• By Company Type - Tier 1 - 30%, Tier 2 - 55% and Tier 3 - 15%
• By Designation - C-level - 30%, Director-level - 35%, Others - 35%
• By Region - North America - 55%, Europe - 15%, APAC - 25%, RoW - 5%

The major players of the sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).

Research Coverage

This report studies the sepsis diagnostics market based on technology, product, pathogen, test type, method, end user, and region. The report studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the four key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis— market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
    • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
      • MARKET SIZE ESTIMATION METHODOLOGY
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
      • RESEARCH DESIGN
      • MARKET DATA VALIDATION AND TRIANGULATION
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • SEPSIS DIAGNOSTICS: MARKET OVERVIEW
    • SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY
    • GEOGRAPHIC ANALYSIS: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT AND REGION
    • SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN
    • SEPSIS DIAGNOSTICS MARKET, BY METHOD
    • GEOGRAPHIC SNAPSHOT OF THE SEPSIS DIAGNOSTICS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
    • MICROBIOLOGY
      • Table MICROBIOLOGY MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016–2023 (USD MILLION)
    • MOLECULAR DIAGNOSTICS
      • POLYMERASE CHAIN REACTION
      • PEPTIDE NUCLEIC ACID-FLUORESCENT IN SITU HYBRIDIZATION
      • MICROARRAYS
      • SYNDROMIC PANEL-BASED TESTING
        • Table MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016–2023 (USD MILLION)
    • IMMUNOASSAY
      • Table IMMUNOASSAY MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016–2023 (USD MILLION)
    • FLOW CYTOMETRY
      • Table FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016–2023 (USD MILLION)
    • MICROFLUIDICS
      • Table MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016–2023 (USD MILLION)
    • BIOMARKERS
      • Table BIOMARKERS MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016–2023 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
    • INSTRUMENTS
      • Table SEPSIS DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • BLOOD CULTURE MEDIA
      • Table SEPSIS DIAGNOSTIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2016–2023 (USD MILLION)
    • ASSAYS & REAGENTS
      • Table SEPSIS DIAGNOSTIC ASSAYS & REAGENTS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • SOFTWARE
      • Table SEPSIS DIAGNOSTIC SOFTWARE MARKET, BY REGION, 2016–2023 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY METHOD
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
    • CONVENTIONAL DIAGNOSTICS
      • Table CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • AUTOMATED DIAGNOSTICS
      • Table AUTOMATED DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
    • BACTERIAL SEPSIS
      • Table BACTERIAL SEPSIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table BACTERIAL SEPSIS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • GRAM-NEGATIVE BACTERIAL SEPSIS
        • Table BACTERIAL CAUSES OF ADULT SEPSIS
      • GRAM-POSITIVE BACTERIAL SEPSIS
        • Table BACTERIAL CAUSES OF ADULT SEPSIS
    • FUNGAL SEPSIS
      • Table FUNGAL SEPSIS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • OTHER PATHOGENS
      • Table OTHER PATHOGENS MARKET, BY REGION, 2016–2023 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
    • LABORATORY TESTS
      • Table LABORATORY POINTERS OF SEPSIS
      • Table LABORATORY TESTS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • POINT-OF-CARE TESTS
      • Table POINT-OF-CARE TESTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • HOSPITALS
      • Table SEPSIS DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2016–2023 (USD MILLION)
    • PATHOLOGY & REFERENCE LABORATORIES
      • Table SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
  • SEPSIS DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table SEPSIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • US
        • Table US: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table US: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table US: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table US: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table US: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table US: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • CANADA
        • Table CANADA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table CANADA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table CANADA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table CANADA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table CANADA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table GERMANY: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table GERMANY: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table GERMANY: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table FRANCE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table FRANCE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table FRANCE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • UK
        • Table UK: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table UK: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table UK: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table UK: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table UK: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table UK: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table ROE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table ROE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table ROE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table ROE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table ROE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • ASIA PACIFIC
      • Table APAC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table APAC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
      • Table APAC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table APAC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
      • Table APAC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
      • Table APAC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
      • Table APAC: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • JAPAN
        • Table JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table JAPAN: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table JAPAN: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table JAPAN: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table JAPAN: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • CHINA
        • Table CHINA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table CHINA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table CHINA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table CHINA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table CHINA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table CHINA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • INDIA
        • Table INDIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table INDIA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table INDIA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table INDIA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table INDIA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table INDIA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: SEPSIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • Table ROW: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
      • Table ROW: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table ROW: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
      • Table ROW: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
      • Table ROW: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
      • Table ROW: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • LATIN AMERICA
        • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • MIDDLE EAST & AFRICA
        • Table MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES AND APPROVALS, 2015–2017
      • PARTNERSHIPS AND COLLABORATIONS, 2015–2018
      • MERGERS AND ACQUISITIONS
  • COMPANY PROFILES
    • BIOMÉRIEUX
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • T2 BIOSYSTEMS
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • LUMINEX
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BECTON, DICKINSON, AND COMPANY (BD)
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ROCHE DIAGNOSTICS (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BRUKER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABBOTT
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • IMMUNEXPRESS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • RESPONSE BIOMEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AXIS-SHIELD DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • CYTOSORBENTS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MITSUBISHI CHEMICAL EUROPE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • EKF DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report